Treatment type: Cell therapies

  • Stem Cells: Hope on the horizon for preterm babies

    Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.…  Read more

    Dr Lindsay Zhou and Associate Professor Atul Malhotra
  • Uncovering the cellular secrets of RNA editing

    Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.…  Read more

    L-R: Scott Taylor, Ankita Goradia, Jacki Heraud-Farlow and Carl Walkley
  • New treatment hope for perinatal lung and brain injury

    Hudson Institute researchers are lifting the lid on a treatment promising the benefits of stem cells but none of the drawbacks, offering potential to reduce the lifelong impacts of perinatal lung and brain injuries.…  Read more

    Tamara Yawno, Naveen Kumar, Mikee Inocencio, Hamid Bidkhori
  • Grant to improve understanding of UCB stem cell treatment

    Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.…  Read more

    Tayla Penny researching UCB stem cell treatment
  • How cell death affects your health

    A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. …  Read more

    Mitochondria
  • Research transforming pelvic organ prolapse treatment

    This research has the potential to revolutionise therapies for pelvic floor regeneration and enable personalised medicine for women.…  Read more

    POP | Images showing cellular expression on 3D printed degradable pelvic meshes
  • World-first cord blood trial helps unborn stroke victims

    When unborn babies suffer a stroke, the potential damage can be life-long, so Hudson Institute of Medical Research is aiming to change that using the stem cells found in umbilical cord blood (UCB).…  Read more

    Laren and Chase Whalley with Associate Professor Atul Malhotra
  • Pelvic organ prolapse cure closer

    New ways to prevent and cure pelvic organ prolapse (POP) are a big step closer, thanks to major funding for pioneering research at Hudson Institute.…  Read more

    Top: Associate Professor Anna Rosamilia, Professor Jerome Werkmeister, Professor Caroline Gargett, Dr Shayanti Mukherjee. Bottom: Dr Saeedeh Darzi, Dr Kallyanashis Paul, Dr Shayanti Mukherjee
  • Better treatments sooner: Hudson unveils RNAte Platform

    Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.…  Read more

    Natalia Sampaio In the lab of the RNAte Platform at Hudson Institute
  • Bright ideas attract major funding

    Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.…  Read more

    NHMRC Ideas Grants 2023